« Back
Home /
Cyclin D1 [DCS-6]

Cyclin D1 [DCS-6]

Item no.	20-272-190250
Manufacturer	GENWAY
Amount	0.1 ml
Category	Oncology Neuroscience Neural Lineage Markers Antibodies By Cell Type Blastoma Carcinoma Cell Biology Cell Status Immunohistochemistry Immunoprecipitation Western Blot Immunocytochemistry Proliferation Primary Antibodies By Organ Bladder Cancer Colorectal Cancer Testicular & Prostate Cancer
Type	Antibody
Applications	WB, IP, IHC, ICC
Clone	DCS-6
Specific against	other
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	GWB-36F9FE
Similar products	20-272-190250
Available
Genway ID:	GWB-36F9FE
Clone:	DCS-6
Isotype:	IgG2a
Immunogen:	Recombinant full length protein (Human).
Antigen Species:	Human
Specificity:	Does not cross-react with other D-type cyclins.
Target:	Cyclin D1
Localization:	Nuclear
Concentration:	2. 70 mg/ml Storage
Preservative:	15mM Sodium Azide
Application Note:	ICC: Use at an assay dependent dilution. IHC-P: Use at an assay dependent dilution. Perform heat mediated antigen retrieval via the microwave method before commencing with IHC staining protocol. IP: Use at an assay dependent dilution. WB: Use at a dilution of 1/200. Detects a band of approximately 36 kDa. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user. Cellular
Localization:	Nuclear During each cell cycle cyclins undergo periodic accumulation and destruction. As key regulators of the cell cycle the cyclins control important transitions by activating Cdks. Early in the G1 phase of the cell cycle cyclin D1 induction is followed by cyclin E induction. This sequential progression is marked early on in G1 by the activation of Cdk4 and in mid to late G1 by the activation of Cdk2 and the hyperphosphorylation of pRB. The final transition into S phase is thought to be dependent on the increased expression and association of cyclin E and Cdk2.
Function:	Essential for the control of the cell cycle at the G1/S (start) transition.
Subunit:	Interacts with the CDK4 and CDK6 protein kinases to form a serine/threonine kinase holoenzyme complex. The cyclin subunit imparts substrate specificity to the complex.
Disease:	A chromosomal aberration involving CCND1 may be a cause of B-lymphocytic malignancy particularly mantle-cell lymphoma (MCL). Translocation t(11; 14)(q13; q32) with immunoglobulin gene regions. Activation of CCND1 may be oncogenic by directly altering progression through the cell cycle.
Disease:	A chromosomal aberration involving CCND1 may be a cause of parathyroid adenomas [MIM:168461]. Translocation t(11; 11)(q13; p15) with the parathyroid hormone (PTH) enhancer.
Disease:	A chromosomal aberration involving CCND1 may be a cause of multiple myeloma [MIM:254500]. Translocation t(11; 14)(q13; q32) with the IgH locus.
Similarity:	Belongs to the cyclin family. Cyclin D subfamily.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.1 ml

available

Delivery expected until 9/27/2024

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail